v3.26.1
Fair Value Measurements and Fair Value of Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2025
Fair Value Measurements and Fair Value of Financial Instruments [Abstract]  
Schedule of Fair Value Consisted Assets and Liabilities

As of December 31, 2025, the Company did not have any assets measured at fair value on a recurring basis. The Company’s liabilities measured at fair value consisted of the following at December 31, 2025:

 

   Fair Value at December 31, 2025 
   Total   Level 1   Level 2   Level 3 
Liabilities:                
Warrant liability  $22,561   $
    —
   $
    —
   $22,561 
Total liabilities  $22,561   $
   $
   $22,561 
Schedule of Reconciliation of Liabilities for Level 3 Investments

The table below provides a summary of changes in the estimated fair value of the Company’s Level 3 assets and liabilities:

 

   Convertible Note Investment –
Valkyrie
Sciences Holding
LLC
   Warrant
Liability
 
Balance at January 1, 2025  $
   $
 
Purchase of convertible note   2,000    
 
Interest income accrued on convertible note   39    
 
Pre-funded and Common Warrants issued in connection with 2025 Public Offerings   
    41,303 
Exercise of Warrants   
    (19,338)
Change in fair value   
    596 
Provision for expected credit losses   (2,039)     
Balance at December 31, 2025  $
   $22,561